143 related articles for article (PubMed ID: 14677169)
1. WHO-ILAR COPCORD perspectives past, present, and future.
Darmawan J; Muirden KD
J Rheumatol; 2003 Nov; 30(11):2312-4. PubMed ID: 14677169
[No Abstract] [Full Text] [Related]
2. Epidemiology of rheumatic musculoskeletal disorders in the developing world.
Chopra A; Abdel-Nasser A
Best Pract Res Clin Rheumatol; 2008 Aug; 22(4):583-604. PubMed ID: 18783739
[TBL] [Abstract][Full Text] [Related]
3. Case study: World Health Organization-International League of Associations for Rheumatology Community-Oriented Programme for the Control of Rheumatic Diseases (WHO-ILAR COPCORD) in Indonesia and Brazil.
Darmawan J; Ferraz MB; Muirden KD; Tugwell P
Int J Technol Assess Health Care; 1995; 11(4):700-8. PubMed ID: 8567202
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with rheumatic complaints: a WHO-ILAR COPCORD study in Shantou, Southeast China.
Zeng QY; Darmawan J; Xiao ZY; Chen SB; Chen R; Lin K; Wigley R; Chen SL; Zhang NZ
J Rheumatol; 2005 May; 32(5):920-7. PubMed ID: 15868631
[TBL] [Abstract][Full Text] [Related]
5. WHO-ILAR COPCORD pilot study in Tehran, Iran.
Davatchi F; Jamshidi AR; Banihashemi AT
J Rheumatol; 2006 Aug; 33(8):1714. PubMed ID: 16881137
[No Abstract] [Full Text] [Related]
6. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran.
Davatchi F; Jamshidi AR; Banihashemi AT; Gholami J; Forouzanfar MH; Akhlaghi M; Barghamdi M; Noorolahzadeh E; Khabazi AR; Salesi M; Salari AH; Karimifar M; Essalat-Manesh K; Hajialiloo M; Soroosh M; Farzad F; Moussavi HR; Samadi F; Ghaznavi K; Asgharifard H; Zangiabadi AH; Shahram F; Nadji A; Akbarian M; Gharibdoost F
J Rheumatol; 2008 Jul; 35(7):1384. PubMed ID: 18464299
[TBL] [Abstract][Full Text] [Related]
7. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model.
Joshi VL; Chopra A
J Rheumatol; 2009 Mar; 36(3):614-22. PubMed ID: 19208598
[TBL] [Abstract][Full Text] [Related]
8. Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey.
Minaur N; Sawyers S; Parker J; Darmawan J
J Rheumatol; 2004 May; 31(5):965-72. PubMed ID: 15124258
[TBL] [Abstract][Full Text] [Related]
9. COPCORD--an unrecognized fountainhead of community rheumatology in developing countries.
Chopra A
J Rheumatol; 2004 Dec; 31(12):2320-2. PubMed ID: 15570627
[No Abstract] [Full Text] [Related]
10. The WHO-ILAR COPCORD Bhigwan (India) model: foundation for a future COPCORD design and data repository.
Chopra A
Clin Rheumatol; 2006 Jul; 25(4):443-7. PubMed ID: 16612674
[TBL] [Abstract][Full Text] [Related]
11. Towards elucidation of the epidemiology of the rheumatic diseases in Mexico. COPCORD studies in the community.
Cardiel MH; Burgos-Vargas R
J Rheumatol Suppl; 2011 Jan; 86():1-2. PubMed ID: 21196591
[No Abstract] [Full Text] [Related]
12. Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology.
Courage UU; Stephen DP; Lucius IC; Ani C; Oche AO; Emmanuel AI; Olufemi AO
Clin Rheumatol; 2017 Nov; 36(11):2509-2516. PubMed ID: 28447235
[TBL] [Abstract][Full Text] [Related]
13. Validity of the COPCORD core questionnaire as a classification tool for rheumatic diseases.
Goycochea-Robles MV; Sanin LH; Moreno-Montoya J; Alvarez-Nemegyei J; Burgos-Vargas R; Garza-Elizondo M; Rodríguez-Amado J; Madariaga MA; Zamudio JA; Cuervo GE; Cardiel-Ríos MH; Peláez-Ballestas I;
J Rheumatol Suppl; 2011 Jan; 86():31-5. PubMed ID: 21196597
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of oral aphthosis in a normal population in Iran: a WHO-ILAR COPCORD study.
Davatchi F; Tehrani-Banihashemi A; Jamshidi AR; Chams-Davatchi C; Gholami J; Moradi M; Akhlaghi M; Foroozanfar MH; Barghamdi M; Noorolahzadeh E; Samadi F; Hadj-Aliloo M; Ghaznavi K; Ghaznavi K; Soroosh M; Khabazi A; Salari AH; Sharif SK; Karimifar M; Salessi M; Essalat-Manesh K; Nadji A; Shahram F
Arch Iran Med; 2008 Mar; 11(2):207-9. PubMed ID: 18298301
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology.
Peláez-Ballestas I; Sanin LH; Moreno-Montoya J; Alvarez-Nemegyei J; Burgos-Vargas R; Garza-Elizondo M; Rodríguez-Amado J; Goycochea-Robles MV; Madariaga M; Zamudio J; Santana N; Cardiel MH;
J Rheumatol Suppl; 2011 Jan; 86():3-8. PubMed ID: 21196592
[TBL] [Abstract][Full Text] [Related]
16. Musculoskeletal pain in Malaysia: a COPCORD survey.
Veerapen K; Wigley RD; Valkenburg H
J Rheumatol; 2007 Jan; 34(1):207-13. PubMed ID: 17216688
[TBL] [Abstract][Full Text] [Related]
17. Rheumatic diseases. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1992; 816():1-59. PubMed ID: 1561791
[No Abstract] [Full Text] [Related]
18. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach.
Senna ER; De Barros AL; Silva EO; Costa IF; Pereira LV; Ciconelli RM; Ferraz MB
J Rheumatol; 2004 Mar; 31(3):594-7. PubMed ID: 14994410
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study.
Haq SA; Darmawan J; Islam MN; Uddin MZ; Das BB; Rahman F; Chowdhury MA; Alam MN; Mahmud TA; Chowdhury MR; Tahir M
J Rheumatol; 2005 Feb; 32(2):348-53. PubMed ID: 15693098
[TBL] [Abstract][Full Text] [Related]
20. Recommendations from the Community Oriented Program for Control of Rheumatic Disease for data collection for the measurement and monitoring of health in developing countries.
Darmawan J;
Clin Rheumatol; 2007 Jun; 26(6):853-7. PubMed ID: 17364136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
